Dr. Jason Alcorn covers steps 4 and 5 of the GUIDE Communication Framework, explaining how to direct the patient and carer to additional support and the importance of empowering the patient.

Watch the video and download the slides


The GUIDE Communication Framework: Strengthening shared decision-making between nmCRPC patients and the healthcare team

This is the last in a series of three newsletters explaining the GUIDE Communication Framework, a simple 5-step approach to optimise the role of the nurse in strengthening shared decision-making between nmCRPC patients and their healthcare team.

GUIDE’s five letters each represent a crucial step in your conversations with patients with prostate cancer.

  • Gain insight into goals of treatment and care
  • Understand gaps in the patient's knowledge
  • Inform and educate
  • Direct to additional support
  • Empower the patient

Dr. Jason Alcorn explains how to Direct the patient and the carer to additional support and the importance of Empowering the patient, making them feel they can actively participate in the shared decision-making and treatment process, and why these steps are an important part of a successful treatment journey.

In the first newsletter, Veerle Lamotte covered steps 1 and 2 of the GUIDE framework and explained why it’s important to Gain insight into the goals of treatment and care as a first step in supporting your patients along the agreed treatment journey and how to Understand the gaps in the patient’s knowledge, allowing you to prioritise where you focus when it comes to informing and educating the patient.

In the second newsletter, Joanie Pfahl and Jennifer Sutton covered step 3 of the GUIDE Communication Framework and explain the importance of Informing and educating the patient, and why it is essential for nurses to have up-to-date knowledge about the disease and common symptoms, key studies relating to nmCRPC, treatment aims and options, potential side effects and proactive management as addressing patients’ knowledge gaps in the right way is critical in managing their treatment successfully.

Hello, I am Dr Jason Alcorn and I'm from The Mid Yorkshire Hospitals NHS Trust in the United Kingdom.

I'm going to be talking about the strengthening shared decision-making between non-metastatic castrate-resistant prostate cancer patients and the healthcare team.

Directing the patient to additional support and Empowering the patient

This is using the GUIDE Communication Framework. I will be talking about directing to additional support and empowering the patient. If we consider the first step is directing patients to additional support, we must consider all the local options available in our areas, centres or regions.

We must consider the information provision to patients and ensuring the patient understands the information provided.

Empowering the patient by involving them in the shared decision-making process can increase the likelihood of treatment success.

As Uro-oncology nurses, we play a vital role in this process, we undertake holistic reviews of patients and ensure the patients have the right knowledge.  Factors to consider are: the physical and psycho-social aspects, such as any existing comorbidities, or barriers that the patients may face such as psychological distress of the disease.

Also understanding the treatment options of darolutamide, apalutamide and enzalutamide. These may present with potential drug interactions.  We must understand the safety profile or any polypharmacy that the patient may have and also consider bone health.

We must take into account the quality of life of the patient and also their wishes, these are paramount to involving them in their treatment and decision-making process.

To download the slides go to gunursesconnect.cor2ed.com. Thank you for listening on behalf of GU Nurses CONNECT and remember - download the slides.

Jason Alcorn is the Nurse Consultant for Uro-oncology and Andrology at the Mid Yorkshire Hospitals NHS Trust.  He has worked at the Trust for 20 years. The Mid Yorkshire Hospitals NHS Trust is a specialist cancer centre for urological cancers. Jason started in the nursing profession after a career in the military.  After completing a Bachelor’s degree developing student nurse resources, he then studied for a Master’s degree seeking to understand registered nurse understanding of delegation to healthcare assistants.  This led to him being a fellow of the higher education academy and a registered teacher.  He then studied for a professional doctorate seeking to understand why patients withdraw early from Bacillus Calmette-Guerin treatment for urothelial cancer. Jason has presented at several national and international conferences, as well as running workshops locally and in the Middle East on behalf of EAUN, and he has also published several articles from his research activity.  He is an active board member of the European Association of Urological Nurses (EAUN) and his responsibilities on the board include education, accreditation and endorsement. __________________________

Programme summary
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GU NURSES CONNECT

GU NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer, and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

animated-video Animated Video
Oncology 
Managing ADC toxicities in HER2+ metastatic breast cancer

Spotlight on nausea and vomiting

Experts
Dr Sara Tolaney
Endorsed by
ICAN international cancer advocacy network
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Aug 2025

Educational programme supported by an Independent Educational Grant from AstraZeneca.
Oncology 
The latest developments in BRAF-mutant and MSI-H mCRC

Expert insights on recent clinical and real-world data

Experts
Prof. Chiara Cremolini
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Jul 2025

This content is intended for HCPs outside the UK & ROI only. The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution. This programme is supported by an Independent Educational Grant from Pierre Fabre Laboratories.  The programme is, therefore, independent; the content is not influenced by Pierre Fabre Laboratories and is under the sole responsibility of the experts. 
publication Scientific Publication
Oncology 
LEAP-012 publication

Expert insights on multimodal treatment for intermediate HCC

Experts
Prof. Arndt Vogel
Endorsed by
DiCE Global Liver Institute Blue Faery
ELPA
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jun 2025

This programme has been sponsored by Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of, or speakers involved in this programme.
Oncology Hemato-oncology 
Innovating relapsed refractory multiple myeloma care

Unmet needs, therapy management, and real-world experience

Experts
Assoc. Prof. María Victoria Mateos, Assoc. Prof. Karthik Ramasamy, Assoc. Prof. Elena Zamagni
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
ipcv Interactive Patient Case Video (IPCV)
Oncology 
NTRK fusion testing and treatment in pediatric sarcoma

Make decisions for a young patient during his cancer journey

Experts
Dr Theodore Laetsch
Endorsed by
NTRKers
  • clock MIN
  • calendar Jun 2025

Educational programme supported by an Independent Educational Grant from Bayer.
micro-learning Micro learning - Video, slides and more

Module

4

of 4

module
Oncology 
Navigating advanced HCC: treatment strategies beyond immunotherapy (IO)

Module 4: Treatment strategies for patients ineligible for IO or those with progression on IO 

Experts
Assoc. Prof. Lorenza Rimassa, Dr Amit Singal
Endorsed by
DiCE ELPA Global Liver Institute
Blue Faery AASLD
  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Jun 2025

Educational programme supported by an Independent Educational Grant from Bayer.